O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 3.955 EUR -0.25% Market Closed
Market Cap: 76.2m EUR
Have any thoughts about
Optomed Oyj?
Write Note

Optomed Oyj
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Optomed Oyj
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
O
Optomed Oyj
OMXH:OPTOMED
Net Change in Cash
-€1.4m
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Revenio Group Oyj
OMXH:REG1V
Net Change in Cash
-€5.8m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
-21%
M
Modulight Oyj
OMXH:MODU
Net Change in Cash
-€18.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Net Change in Cash
€5.7m
CAGR 3-Years
37%
CAGR 5-Years
47%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Net Change in Cash
€904.1k
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Net Change in Cash
-€305k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
16%
No Stocks Found

Optomed Oyj
Glance View

Market Cap
77.5m EUR
Industry
Health Care

Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. The company is headquartered in Oulu, Oulun and currently employs 115 full-time employees. The company went IPO on 2019-12-09. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.

OPTOMED Intrinsic Value
5.584 EUR
Undervaluation 29%
Intrinsic Value
Price
O

See Also

What is Optomed Oyj's Net Change in Cash?
Net Change in Cash
-1.4m EUR

Based on the financial report for Dec 31, 2023, Optomed Oyj's Net Change in Cash amounts to -1.4m EUR.

What is Optomed Oyj's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
45%

The average annual Net Change in Cash growth rates for Optomed Oyj have been 45% over the past three years .

Back to Top